Molecular Identification and Evaluation of Resistance to Antifungal Drugs in <i>Candida</i> Species Isolated From Diaper Rash of Neonates

The selection of itraconazole and fluconazole-resistant isolates of <i>candida</i> among pediatric population may be a concern because <i>C. albicans</i> can be involved in invasive infections. The treatment of recurrent invasive candidiasis, needing repeated course of fluconazole or itraconazole, could be a risk factor for selecting resistant isolates. In addition, as the liposomal amphotericin B is no more commercialized in our country, a higher drug selection pressure for azoles may be expected in the future.